Valuation: Manac Incorporated

Market Cap 8.32B 52.76M 46.88M 43.75M 39.88M 75.21M 5.07B 75.91M 529M 205M 2.59B 198M 194M P/E 2025
-5.24x
P/E 2026 10.2x
Enterprise Value 5.13B 32.52M 28.89M 26.97M 24.58M 46.36M 3.13B 46.79M 326M 126M 1.6B 122M 119M EV / Sales 2025
0.21x
EV / Sales 2026 0.43x
Free-Float
45.45%
Yield 2025
2.16%
Yield 2026 1.28%
Manager TitleAgeSince
Director of Finance/CFO 45 01/06/2025
President 76 01/06/2022
Director TitleAgeSince
Chairman 76 01/10/2021
Director/Board Member 67 01/10/2021
Director/Board Member 76 01/10/2021
Change 5-day change 1-year change 3-year change Capi.($)
-0.27%-0.68% - - 52.76M
+0.05%+2.39%+23.72%+38.24% 71.1B
+1.06%-0.98%+14.35%+19.18% 48.38B
-0.08%-3.51%-0.77%+20.02% 15.5B
-1.18%-0.94%+40.82%+74.48% 13.91B
-1.04%-2.35%+36.92%+21.58% 9.85B
+0.10%-1.61%+10.86%-19.59% 9.52B
+0.19%-0.77%+14.56% - 8.91B
-0.48%-0.26%+116.44%-9.33% 8.75B
+0.65%-1.60%-14.35%+10.74% 7.68B
Average -0.10%-1.05%+26.95%+19.42% 21.51B
Weighted average by Cap. +0.16%-0.03%+22.94%+27.18%

Financials

2025 2026
Net sales 9.3B 58.99M 52.41M 48.92M 44.59M 84.09M 5.67B 84.87M 592M 229M 2.9B 221M 217M 10.99B 69.7M 61.93M 57.8M 52.68M 99.36M 6.7B 100M 699M 271M 3.43B 262M 256M
Net income -895M -5.67M -5.04M -4.71M -4.29M -8.09M -546M -8.16M -56.95M -22.07M -279M -21.31M -20.84M 781M 4.95M 4.4M 4.11M 3.74M 7.06M 476M 7.12M 49.69M 19.26M 243M 18.59M 18.19M
Net Debt -2.77B -17.54M -15.59M -14.55M -13.26M -25.01M -1.69B -25.24M -176M -68.22M -862M -65.87M -64.44M -3.19B -20.24M -17.98M -16.78M -15.3M -28.85M -1.95B -29.12M -203M -78.7M -995M -75.98M -74.33M
Logo Manac Incorporated
Manac Chemical Partners Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of chemical and industrial drugs, pharmaceuticals and veterinary drugs, as well as the operation and management of group companies. The fine chemicals business is engaged in the provision of functional materials and intermediates for pharmaceutical, agrochemical and high-tech fields, as well as intermediates for information-related fields. The flame retardant business is engaged in the provision of products to industrial fields such as electrical products, office automation (OA) equipment and automobile parts. The health support business is engaged in the provision of raw materials for artificial dialysis drugs, raw materials for antibacterial agents, and reagents. The Company is also engaged in the import and export of chemicals, the leasing of warehouses, and the development, manufacture and sale of iodine-related products.
Employees
246